Table 1 Patient characteristics in the treatment group
Characteristics | Experimental group | Control group | p value |
|---|---|---|---|
n (%) | n (%) | ||
Age | p = 0.643 | ||
≥ 65 years | 17(63) | 13(56.5) | |
< 65 years | 10(37) | 10(43.5) | |
Gender | p = 0.811 | ||
Male | 15(55.6) | 12(52.2) | |
Female | 12(44.4) | 11(47.8) | |
Tumour site | p = 0.817 | ||
Head and neck | 3(11.1) | 2(8.7) | |
Chest | 10(37.0) | 10(43.5) | |
Abdomen | 11(40.7) | 10(43.5) | |
Other | 3(11.1) | 1(4.3) | |
Disease stage | p = 0.167 | ||
II | 1(3.7) | 0(0) | |
III | 7(25.9) | 2(8.7) | |
IV | 19(70.4) | 21(91.3) | |
PS | p = 0.403 | ||
0 | 0(0) | 1(4.3) | |
1 | 20(74.1) | 14(60.9) | |
2 | 7(25.9) | 8(34.8) | |
Chemotherapeutic drugs | p = 0.475 | ||
Platinum ± 5-FU | 9(33.3) | 5(21.7) | |
Paclitaxel | 8(29.6) | 11(47.8) | |
EN Huan | 2(7.4) | 2(8.7) | |
Target | 6(22.2) | 2(8.7) | |
Other | 2(7.4) | 3(13) | |
Previous chemotherapy | p = 0.114 | ||
Yes | 20(74.1) | 21(91.3) | |
No | 7(25.9) | 2(8.7) | |
Previous radiotherapy | p = 0.857 | ||
Yes | 4(14.8) | 3(13) | |
No | 23(85.2) | 20(87) | |